Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taro Pharmaceutical Industries Ltd.

www.taro.com

Latest From Taro Pharmaceutical Industries Ltd.

Zero Count Adds Up To 70,000-Bottle Ranitidine Recall For AuroMedics

Additional recent recalls include 19,000 bottles of product marketed by Fitoterapia USA and labeled as liquid vitamin C but found to contain erectile dysfunction drug taldalafil .Ongoing testing of ranitidine drugs by FDA and manufacturers led to Aurobindo Pharma USA recall of one lot of OTC 150-mg tablets.

Consumer FDA

Teva And Apotex Fail To Bar Sun And Sandoz From Canadian Rivaroxaban Case

Sandoz and Sun’s Taro can be added to a pending trial over Canadian patents protecting Bayer’s Xarelto cardiovascular drug. Teva and Apotex had sought to be alone in their dispute over the rivaroxaban brand.

Intellectual Property Canada

Unsealed Price-Fixing Complaint Reveals Emails

Emails between major generics firms including Teva, Sandoz and Mylan have been revealed after a court unsealed a complaint filed by 44 US states claiming widespread price-fixing among numerous industry players.

Regulation Pricing Strategies

Deal Watch: Astellas/Cytokinetics Extend Partnership, Make Progress On SMA Candidate

The two firms hope improvement in the six-minute walk test might be accepted by the US FDA as registrational endpoint for reldesemtiv in spinal muscular atrophy. Blackstone acquires Clarus, while Merck licenses TriNKETs from Dragonfly.

Deals Business Strategies
See All

Company Information

UsernamePublicRestriction

Register